Clinical and Diagnostic Laboratory Immunology, September 1999, p. 718-724, Vol. 6, No. 5
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Division of Allergy,
Received 15 March 1999/Returned for modification 7 June
1999/Accepted 9 July 1999
Peripheral blood mononuclear cells (PBMC) of human immunodeficiency
virus (HIV)-infected children, age-matched HIV-seronegative controls,
and HIV-infected asymptomatic and symptomatic adults were compared for
their ability to mediate antibody-dependent cellular cytotoxicity
(ADCC) and natural killer (NK) cell-mediated cytotoxicity against
target cells expressing HIV or herpes simplex virus (HSV) antigens.
Target cells consisted of CD4 lymphocytes purified from PBMC of
HIV-seronegative adults and incubated with the IIIB strain of HIV,
HUT78 cells chronically infected with IIIB, and HSV-infected human
fibroblasts. PBMC of asymptomatic HIV-infected adults were generally
able to lyse CD4 cells expressing HIV antigens. Direct correlation was
found between the magnitude of lysis and absolute CD4 cell counts in
these individuals. In contrast to these results, PBMC from HIV-infected
children were generally unable to lyse IIIB-expressing CD4 cells,
regardless of the children's clinical status, age, or absolute CD4
cell counts. Cells from HIV-seronegative adults and children did not
directly lyse these target cells either but, in contrast to cells of
HIV-seropositive children, were able to mediate cell lysis when serum
from an HIV-seropositive adult was added. However, effector cells from
these HIV-infected children were able to mediate both ADCC against
HSV-infected fibroblasts and NK cell-mediated cytotoxicity against
IIIB-infected HUT78 cells. Reduced ability of PBMC from vertically
HIV-infected children to mediate ADCC against HIV antigen-expressing
CD4 cells may contribute to rapid progression to AIDS.
*
Corresponding author. Mailing address: UCLA Children's
Hospital, Division of Allergy and Immunology, MDCC, Rm. 22-387, Los Angeles, CA 90095. Phone: (310) 825-6481. Fax: (310) 206-5843. E-mail: uziegner{at}mednet.ucla.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |